In re Blood Reagents Antitrust Litigation, No. 09-2081 (E.D. Pa.)

In the Blood Reagents price fixing case, Faruqi & Faruqi represents a proposed class of direct purchasers of blood reagent products, challenging conspiracy to fix prices, in violation of § 1 of the Sherman Act.  Plaintiffs have alleged that defendants Immucor and Ortho-Clinics Diagnostics, a subsidiary of Johnson & Johnson, consolidated the market for blood reagents in the early 2000s in order to raise the price to supracompetitive levels.  As a result of this alleged conspiracy, plaintiffs paid far more for blood reagents than they would have in a competitive market.  Plaintiffs have settled with Ortho-Clinics Diagnostics and are in the process of seeking Court approval of the settlement in 2012.